Preventing Recurrent Allergic Rhinitis

Primary Prevention Strategy: Continuous Pharmacologic Therapy

The American Academy of Otolaryngology-Head and Neck Surgery recommends continuous daily intranasal corticosteroid therapy combined with allergen avoidance and consideration of immunotherapy for inadequate responders as the most effective prevention strategy for patients with recurrent allergic rhinitis 1, 2
Intranasal corticosteroids should be used continuously throughout allergen exposure periods rather than intermittently, as they are the most effective monotherapy for preventing symptom recurrence and maintaining disease control, particularly important for patients with persistent allergic rhinitis 3, 4, 5

The American Academy of Otolaryngology-Head and Neck Surgery advises specific environmental controls for patients with identified allergens that correlate with clinical symptoms, though the evidence for their efficacy varies 1, 2
For pollen allergies, keeping windows and doors closed during high pollen seasons, avoiding outdoor activities when pollen counts are elevated, and using air conditioning rather than attic fans is recommended 6
For dust mite allergies, consideration of removal of carpeting, use of air filtration systems, allergen-impermeable bed covers, and acaricides is advised 1, 2
For pet allergies, removing pets from the home when feasible, or at minimum excluding them from bedrooms, is recommended 1, 2

The American Academy of Otolaryngology-Head and Neck Surgery suggests allergen immunotherapy (subcutaneous or sublingual) should be offered or referred for patients who have inadequate response to pharmacologic therapy with or without environmental controls, as it is the only treatment that can alter the natural history of allergic rhinitis and prevent recurrence long-term 1, 2, 3
Immunotherapy can prevent development of new allergen sensitivities and reduce the risk of future asthma development, particularly in children 7, 8, 3

The American Academy of Otolaryngology-Head and Neck Surgery recommends assessing and documenting associated conditions that can worsen allergic rhinitis or be worsened by it, including asthma, atopic dermatitis, sleep-disordered breathing, conjunctivitis, rhinosinusitis, and otitis media 1, 2, 9
Over 50% of patients with asthma have allergic rhinitis, and treatment of allergic rhinitis with intranasal corticosteroids can improve asthma control and reduce bronchial hyperreactivity 7, 8, 9

The American Academy of Otolaryngology-Head and Neck Surgery suggests combination pharmacologic therapy should be offered for patients with inadequate response to intranasal corticosteroid monotherapy, particularly combining intranasal corticosteroid with intranasal antihistamine 1, 2, 3
This combination provides greater efficacy than either agent alone for moderate to severe symptoms 3

The American Academy of Otolaryngology-Head and Neck Surgery advises against using oral leukotriene receptor antagonists as primary prevention therapy, as they are less efficacious than intranasal corticosteroids 1, 2, 3
Prolonged use of intranasal decongestants beyond 10 days should be avoided, as this leads to rhinitis medicamentosa (rebound congestion) that worsens the underlying condition 3, 4
Oral corticosteroids should not be used for routine prevention due to significant long-term adverse effects; reserve these only for rare patients with severe intractable symptoms unresponsive to all other treatments 3, 4